Literature DB >> 15805717

Takotsubo (ampulla-shaped) cardiomyopathy associated with microscopic polyangiitis.

Takeo Sato1, Kiyofumi Hagiwara, Aya Nishikido, Shingo Miyamoto, Kota Komiyama, Hiroaki Matsuno, Hideji Hashida, Naoshi Kobayakawa, Osamu Akiyama.   

Abstract

Recently, a cardiac disorder characterized by ballooning and hypokinesis at the apex has been described as takotsubo (ampulla-shaped) cardiomyopathy. We encountered a patient with a rare case of takotsubo cardiomyopathy associated with microscopic polyangiitis. A 70-year-old woman suddenly presented with ventricular dysfunction during the active phase of microscopic polyangiitis. The findings on echocardiograms and electrocardiograms were consistent with those of takotsubo cardiomyopathy. The ventricular dysfunction completely resolved after treatment with 40 mg/day of prednisolone and methylprednisolone pulse therapy. This unique type of cardiomyopathy can be a complication of microscopic polyangiitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805717     DOI: 10.2169/internalmedicine.44.251

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Report of takotsubo cardiomyopathy occurring during cardiopulmonary bypass.

Authors:  Hideshi Itoh; Yoichiro Miyake; Iwao Hioki; Satofumi Tanaka; Manabu Okabe
Journal:  J Extra Corpor Technol       Date:  2007-06

Review 2.  Takotsubo Syndrome - Stress-induced Heart Failure Syndrome.

Authors:  Mary N Sheppard
Journal:  Eur Cardiol       Date:  2015-12

3.  Initial clinical presentation of Takotsubo cardiomyopathy with-a focus on electrocardiographic changes: A literature review of cases.

Authors:  Erick Francisco Sanchez-Jimenez
Journal:  World J Cardiol       Date:  2013-07-26

Review 4.  Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis.

Authors:  Elias Rawish; Thomas Stiermaier; Francesco Santoro; Natale D Brunetti; Ingo Eitel
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.